Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-20-001175

Director acquired 31,780 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hagen Heidi Director 2019-12-31 Grant or award +31,780 32,119 D
Loading xslF345X03/doc4.xml…